Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep338 | Diabetes (pathiophysiology & epitemiology) | ECE2015

Pancreatogenic diabetes

Yahia Seif eldin , Mendis Budd , Crabtree Tom , Seevaratnam Nandini

Aims: Diabetes mellitus secondary to pancreatic disease and pancreatic surgery (pancreatogenic; type 3c) is a discrete entity to common types of diabetes and there are no well established guidelines for its management. At Nottingham University Hospitals, we have set up a multidisciplinary pancreatogenic diabetes clinic since 2008. The aim of this study is to look at the outcome of the clinic since it’s been established.Methods: Case notes and hospit...

ea0011p114 | Clinical case reports | ECE2006

Biochemical screening for ret negative medullary thyroid carcinoma (MTC): a case report highlighting difficulties in the interpretation of pentagastrin stimulated calcitonin testing

Webb DR , Seevaratnam N , Suri M , King P

In cases of ret-oncogene positive Medullary Thyroid Carcinoma (MTC), national guidelines advocate screening of 1st degree relatives with the Pentagastrin Stimulation Test (PST) to identify those with C-cell hyperplasia, and therefore at risk of MTC. Prophylactic thyroidectomy is recommended in those with positive tests. We highlight the difficulties of quantifying risk in the relatives of a ret-negative patient.A 30 year-old man presented with a tender n...

ea0011p194 | Clinical practise and governance | ECE2006

Patients with serum prolactin >20,000 mU/l – review of presentation, management and outcome

Seevaratnam N , Khoo E , Rea R , Mansell P

Introduction: Large prolactinomas are uncommon and there is limited information on their presentation and progression. In this study we reviewed the presenting features, associated endocrinopathy and the response to treatment.Methods: 16 patients (aged 20–80 years, 75% male) were identified from our endocrine database as presenting with prolactin >20,000 mU/l between 1985 and 2005.Results: 75% of patients presented with ma...

ea0034p273 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Familial adult hyperinsulinism due to genetic glucokinase activation: implications for therapeutic use of glucokinase activators

Challis B G , Harris J , Sleigh A , Orme S M , Seevaratnam N , Dhatariya K , Simpson H L , Semple R K

Glucokinase (GCK) serves as the blood glucose ‘sensor’ in pancreatic β-cells, being critically involved in transducing elevated blood glucose into increased insulin secretion. Inactivating GCK mutations cause a subtype of maturity onset diabetes of the young (MODY), whereas activating mutations are a rare cause of hyperinsulinaemic hypoglycaemia, usually presenting in infancy.We now describe the case of a 60-year-old woman who first presen...